Randomized Double Blind Placebo Controlled Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Nov 2017
At a glance
- Drugs Botulinum toxin B (Primary)
- Indications Hidradenitis suppurativa
- Focus Proof of concept; Therapeutic Use
- 06 Nov 2017 Planned End Date changed from 23 Jun 2018 to 23 Sep 2018.
- 06 Nov 2017 Planned primary completion date changed from 23 Nov 2017 to 23 Mar 2018.
- 06 Nov 2017 Status changed from recruiting to active, no longer recruiting.